Longeveron LLC (LGVN)
Longeveron - Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with MildAlzheimer’s Disease Presented at the Clinical Trials onAlzheimer’s Disease Conference (CTAD 2025)
Longeveron - Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with MildAlzheimer’s Disease Presented at the Clinical Trials onAlzheimer’s Disease Conference (CTAD 2025)
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak financial signals • Minimal market impact expected **Sentiment:** Neutral (50%) **Content type:** Financial